| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $122K | +67.1% | +56.4% |
| SG&A Expense | $434K | +130.9% | +305.6% |
| Operating Income | -$556K | -113.0% | -200.5% |
| Interest Expense | $21K | -57.1% | +61.5% |
| Pre-tax Income | -$582K | -162.6% | -203.1% |
| Net Income | -$492K | -152.9% | -147.2% |
| EPS (Diluted) | -$0.04 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $122K | +369.2% | +542.1% |
| Current Assets | $169K | -18.8% | +576.0% |
| Total Assets | $7.6M | -0.5% | +2708.1% |
| Current Liabilities | $1.5M | +14.2% | +77.1% |
| Total Liabilities | $1.6M | +14.0% | +75.0% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$375K | -123.2% | -162.2% |
| Investing Cash Flow | $2K | +0.0% | — |
| Financing Cash Flow | $308K | — | +177.5% |
| -144.4% |
| -100.0% |
| $2.4M |
| -11.7% |
| +486.0% |